According to Renub Research global Anti-Venom Market was valued at approximately US$ 1.18 billion in 2024 and is projected to reach around US$ 2.07 billion by 2033, growing at a CAGR of 6.51% from 2025 to 2033. The increasing incidence of snakebites worldwide, particularly in Asia, Africa, and Latin America, remains the primary market driver. Additionally, advancements in biotechnology, the development of more efficient and safer antivenin formulations, and enhanced global healthcare initiatives are accelerating market expansion. Governments and international health organizations are increasingly prioritizing anti-venom availability, distribution, and affordability, supporting strong market growth during the forecast period.
Global Anti-Venom Market OverviewAnti-venom, also known as antivenin, is a lifesaving biological drug derived from animal antibodie…